Bishal Gyawali, MD, PhD, Receives Young Health Researcher Award From Nepali Government
At the Sixth National Summit of Health and Population Scientists, held in Kathmandu, Nepal, Bishal Gyawali, MD, PhD, was awarded the Mrgendra Samjhana Medical Trust Young Researcher Award. The annual conference is organized by the Nepal Health Research Council, an autonomous body of the Government of Nepal for coordinating and promoting health research.
Bishal Gyawali, MD, PhD
An International Perspective
Dr. Gyawali is a medical oncologist and scientist in the Division of Cancer Care and Epidemiology at the Queen’s University Cancer Research Institute in Kingston, Ontario, Canada, where he is also Assistant Professor of Public Health Sciences. His mother and father accepted the award on his behalf, and Dr. Gyawali expressed his appreciation on Twitter, saying, “Thank you to my parents, mentors, friends, well-wishers, and everyone who has inspired and supported me in my journey. Your continued support and inspiration are what drive me to continue working in #globaloncology.”
After graduating from Nepal’s Institute of Medicine with seven gold medals, Dr. Gyawali received his PhD from Nagoya University, Japan, as a MEXT scholar. (The MEXT Scholarship is awarded by the Japanese Ministry of Education, Culture, Sports, Science, and Technology to foreign nationals for them to come to Japan to study.) He then practiced as a medical oncologist at Civil Service Hospital in Kathmandu until February 2018, when he began working in the Department of Medicine at Brigham and Women’s Hospital and Harvard Medical School as a research fellow before joining the staff at Queen’s University in March 2019.
Dr. Gyawali is an advocate of the “cancer groundshot,” a term coined to imply that research investment should be made on known high-value interventions in cancer care that are affordable and easy to implement globally. His clinical and research interests include cancer policy, global oncology, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, and supportive care. Dr. Gyawali is active in the oncology and clinical research communities on Twitter: @oncology_bg.